Vice President and Head of Real World Evidence, GSK
Andrew is currently Vice President and Head of Real World Evidence at GSK and is a renowned expert in epidemiological research with specific interest in the utilisation of routine data for research purposes. He acts as an advisor to a number of projects surrounding the development and use of electronic health data and serves on a number of advisory and grant boards as well as serving on the HL7 advisory council. Andrew obtained his DPhil in Statistics at the University of Oxford working with Sir David Cox, where he also completed a post-doc in Infectious Disease Epidemiology. He was a Senior Researcher at the CRUK Cancer Epidemiology Unit at the University of Oxford before taking up an appointment at Amgen where he was most recently Regional Head (EU, EEMEA) in the Center for Observational Research.